Home > Financial Ratios > NEULAND LABORATORIES

NEULAND LABORATORIES
Core EBITDA Growth

    Back to All Ratios
NEULAND LABORATORIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for NEULAND LABORATORIES
Please provide your vote to see the results

NEULAND LABORATORIES Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Core EBITDA Growth(%) 75.89-27.6568.7394.61-11.18

What is the latest Core EBITDA Growth ratio of NEULAND LABORATORIES ?

The latest Core EBITDA Growth ratio of NEULAND LABORATORIES is 75.89 based on Mar2026 Consolidated results.
Year Core EBITDA Growth
Mar202675.89
Mar2025-27.65
Mar202468.73
Mar202394.61
Mar2022-11.18

How is Core EBITDA Growth of NEULAND LABORATORIES Trending?

Years Core EBITDA Growth % Change
Mar2026 75.89
Positive
Mar2025 -27.65
Negative
Mar2024 68.73
-27.35
Mar2023 94.61
Positive
Mar2022 -11.18 -

Other Financial Ratios of NEULAND LABORATORIES


Compare Core EBITDA Growth ratio of peers of NEULAND LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NEULAND LABORATORIES ₹27,515.3 Cr -1.9% -6.7% 44.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹434,280.0 Cr -2.4% -6.2% 11.8% Stock Analytics
DIVIS LABORATORIES ₹246,737.0 Cr -3.3% 1.4% 57.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹181,129.0 Cr -4.5% -4% 35.9% Stock Analytics
CIPLA ₹108,808.0 Cr -3.6% -5% -10.6% Stock Analytics
DR REDDYS LABORATORIES ₹100,170.0 Cr -0.2% 2.5% -3% Stock Analytics


NEULAND LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NEULAND LABORATORIES

-1.9%

-6.7%

44.4%

SENSEX

-2.3%

-6.6%

-12%


You may also like the below Video Courses